These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30741729)

  • 1. A further assessment of a role for Toll-like receptor 4 in the reinforcing and reinstating effects of opioids.
    Yue K; Tanda G; Katz JL; Zanettini C
    Behav Pharmacol; 2020 Apr; 31(2&3):186-195. PubMed ID: 30741729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of Specific Involvement of (+)-Naloxone and (+)-Naltrexone on the Reinforcing and Neurochemical Effects of Cocaine and Opioids.
    Tanda G; Mereu M; Hiranita T; Quarterman JC; Coggiano M; Katz JL
    Neuropsychopharmacology; 2016 Oct; 41(11):2772-81. PubMed ID: 27296151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous self-administration of etonitazene alone and combined with cocaine in rhesus monkeys: comparison with heroin and antagonism by naltrexone and naloxonazine.
    Achat-Mendes C; Valdez GR; Platt DM; Rowlett JK; Spealman RD
    Psychopharmacology (Berl); 2009 Jun; 204(3):489-98. PubMed ID: 19225763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid activation of toll-like receptor 4 contributes to drug reinforcement.
    Hutchinson MR; Northcutt AL; Hiranita T; Wang X; Lewis SS; Thomas J; van Steeg K; Kopajtic TA; Loram LC; Sfregola C; Galer E; Miles NE; Bland ST; Amat J; Rozeske RR; Maslanik T; Chapman TR; Strand KA; Fleshner M; Bachtell RK; Somogyi AA; Yin H; Katz JL; Rice KC; Maier SF; Watkins LR
    J Neurosci; 2012 Aug; 32(33):11187-200. PubMed ID: 22895704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chronic delivery of the Toll-like receptor 4 antagonist (+)-naltrexone on incubation of heroin craving.
    Theberge FR; Li X; Kambhampati S; Pickens CL; St Laurent R; Bossert JM; Baumann MH; Hutchinson MR; Rice KC; Watkins LR; Shaham Y
    Biol Psychiatry; 2013 Apr; 73(8):729-37. PubMed ID: 23384483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor 4 antagonists reduce cocaine-primed reinstatement of drug seeking.
    Brown KT; Levis SC; O'Neill CE; Levy C; Rice KC; Watkins LR; Bachtell RK
    Psychopharmacology (Berl); 2023 Jul; 240(7):1587-1600. PubMed ID: 37286899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4.
    Wang X; Zhang Y; Peng Y; Hutchinson MR; Rice KC; Yin H; Watkins LR
    Br J Pharmacol; 2016 Mar; 173(5):856-69. PubMed ID: 26603732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the reinforcing potential of samidorphan and naltrexone by fixed and progressive ratio intravenous self-administration testing in heroin-maintained rats.
    Smith SL; Dean RL; Todtenkopf MS; Heal DJ
    J Psychopharmacol; 2019 Mar; 33(3):383-391. PubMed ID: 30676189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4).
    Hutchinson MR; Zhang Y; Brown K; Coats BD; Shridhar M; Sholar PW; Patel SJ; Crysdale NY; Harrison JA; Maier SF; Rice KC; Watkins LR
    Eur J Neurosci; 2008 Jul; 28(1):20-9. PubMed ID: 18662331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone attenuation of conditioned but not primary reinforcement of nicotine in rats.
    Liu X; Palmatier MI; Caggiula AR; Sved AF; Donny EC; Gharib M; Booth S
    Psychopharmacology (Berl); 2009 Mar; 202(4):589-98. PubMed ID: 18807246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral effects of benzylideneoxymorphone (BOM), a low efficacy µ opioid receptor agonist and a δ opioid receptor antagonist.
    Mada S; Gerak LR; Soyer A; Maguire DR; Hu Z; Minervini V; Cunningham CW; France CP
    Psychopharmacology (Berl); 2020 Dec; 237(12):3591-3602. PubMed ID: 32820390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OREX-1019: A Novel Treatment of Opioid Use Disorder and Relapse Prevention.
    Maguire DR; Gerak LR; Cami-Kobeci G; Husbands SM; France CP; Belli B; Flynn P
    J Pharmacol Exp Ther; 2020 Feb; 372(2):205-215. PubMed ID: 31748404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the lateral amygdala in the antiallodynic and reinforcing effects of heroin in rats after peripheral nerve injury.
    Martin TJ; Buechler NL; Kim SA; Ewan EE; Xiao R; Childers SR
    Anesthesiology; 2011 Mar; 114(3):633-42. PubMed ID: 21293255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The opioid antagonist naltrexone reduces the reinforcing effects of Delta 9 tetrahydrocannabinol (THC) in squirrel monkeys.
    Justinova Z; Tanda G; Munzar P; Goldberg SR
    Psychopharmacology (Berl); 2004 Apr; 173(1-2):186-94. PubMed ID: 14668977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential involvement of mu-opioid receptors in the rostral versus caudal nucleus accumbens in the reinforcing effects of heroin in rats: evidence from focal injections of beta-funaltrexamine.
    Martin TJ; Kim SA; Lyupina Y; Smith JE
    Psychopharmacology (Berl); 2002 May; 161(2):152-9. PubMed ID: 11981595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Lasting Effects of Methocinnamox on Opioid Self-Administration in Rhesus Monkeys.
    Maguire DR; Gerak LR; Woods JH; Husbands SM; Disney A; France CP
    J Pharmacol Exp Ther; 2019 Jan; 368(1):88-99. PubMed ID: 30401680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of delta(2)-opioid receptors by naltrindole-5'-isothiocyanate attenuates heroin self-administration but not antinociception in rats.
    Martin TJ; Kim SA; Cannon DG; Sizemore GM; Bian D; Porreca F; Smith JE
    J Pharmacol Exp Ther; 2000 Sep; 294(3):975-82. PubMed ID: 10945849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the NOP agonist SCH221510 on producing and attenuating reinforcing effects as measured by drug self-administration in rats.
    Sukhtankar DD; Lagorio CH; Ko MC
    Eur J Pharmacol; 2014 Dec; 745():182-9. PubMed ID: 25446568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of ethanol responding by centrally administered CTOP and naltrindole in AA and Wistar rats.
    Hyytiä P; Kiianmaa K
    Alcohol Clin Exp Res; 2001 Jan; 25(1):25-33. PubMed ID: 11198711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of opiate antagonists and their quaternary derivatives on heroin self-administration in the rat.
    Koob GF; Pettit HO; Ettenberg A; Bloom FE
    J Pharmacol Exp Ther; 1984 May; 229(2):481-6. PubMed ID: 6716270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.